Argenx
ARGX
#550
Rank
ยฃ30.01 B
Marketcap
ยฃ501.93
Share price
0.90%
Change (1 day)
39.65%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Earnings for Argenx (ARGX)

Earnings in 2024 (TTM): -ยฃ53 Million

According to Argenx 's latest financial reports the company's current earnings are ยฃ1.85 Billion. In 2023 the company made an earning of -ยฃ0.24 Billion, an increase over its 2022 earnings that were of -ยฃ0.58 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Argenx from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -ยฃ53 Million-77.87%
2023 -ยฃ0.24 Billion-58.25%
2022 -ยฃ0.58 Billion
2019 -ยฃ0.16 Billion124.95%
2018 -ยฃ69.59 Million132.04%
2017 -ยฃ29.99 Million54.86%
2016 -ยฃ19.37 Million33%
2015 -ยฃ14.56 Million13.63%
2014 -ยฃ12.82 Million46.25%
2013 -ยฃ8.77 Million